Investigators developed a model of the aberrant epithelial reprogramming observed in idiopathic pulmonary fibrosis using alveolar organoids derived from human-iPSCs stimulated with a cocktail of pro-fibrotic and inflammatory cytokines.
[Life Science Alliance]